Skip to main content
Fig. 2 | BMC Neuroscience

Fig. 2

From: Assessment of brain beta-amyloid deposition in transgenic mouse models of Alzheimer’s disease with PET imaging agents 18F-flutemetamol and 18F-florbetaben

Fig. 2

Overview of PET images sorted by study group. In both AD transgenic and control group, 18F-florbetaben imaging showed much higher cortical retention than did 18F-flutemetamol imaging. Color scale bar represents (from black to red) 0–340 percentage of injected dose per cubic centimeter in 18F-florbetaben image. Color scale bar represents (from black to red) 0–259 percentage of injected dose per cubic centimeter in 18F-flutemetamol image. a 18F-florbetaben image of AD mouse, b 18F-florbetaben image of control mouse, c 18F-flutemetamol image of AD mouse, d 18F-flutemetamol image of control mouse

Back to article page